Lung cancer immunotherapy treatment

Potential marker for success of immunotherapy in the treatment of lung cancer: Lung cancer has the highest mortality rate of all cancers, and treatment options are extremely limited, especially for patients with oncogenic mutations in the KRAS gene. A great deal of hope was invested in the licensing of immune checkpoint inhibitors, but the reality […]

Read More… from Lung cancer immunotherapy treatment

Lung cancer immunotherapy treatment

Potential marker for success of immunotherapy in the treatment of lung cancer: Lung cancer has the highest mortality rate of all cancers, and treatment options are extremely limited, especially for patients with oncogenic mutations in the KRAS gene. A great deal of hope was invested in the licensing of immune checkpoint inhibitors, but the reality […]

Read More… from Lung cancer immunotherapy treatment

Improving immune response to cancer

Researchers discover way to improve immune response: Melbourne researchers have identified a way to improve the immune response in the face of severe viral infections. It is widely known that severe viral infections and cancer cause impairments to the immune system, including to T cells, a process called immune ‘exhaustion’. Overcoming immune exhaustion is a […]

Read More… from Improving immune response to cancer

Improving immune response to cancer

Researchers discover way to improve immune response: Melbourne researchers have identified a way to improve the immune response in the face of severe viral infections. It is widely known that severe viral infections and cancer cause impairments to the immune system, including to T cells, a process called immune ‘exhaustion’. Overcoming immune exhaustion is a […]

Read More… from Improving immune response to cancer

AID/APOBECs defence against SARS-CoV-2

AID/APOBECs among important factors in body’s defence against SARS-CoV-2: Together with their multifaceted action mechanisms, activation-induced cytidine deaminase (AID) and so-called APOBEC proteins are important factors in the body’s immune response and offer fast and effective protection against a large number of DNA and RNA viruses. The task of AID is to strengthen the human […]

Read More… from AID/APOBECs defence against SARS-CoV-2

AID/APOBECs defence against SARS-CoV-2

AID/APOBECs among important factors in body’s defence against SARS-CoV-2: Together with their multifaceted action mechanisms, activation-induced cytidine deaminase (AID) and so-called APOBEC proteins are important factors in the body’s immune response and offer fast and effective protection against a large number of DNA and RNA viruses. The task of AID is to strengthen the human […]

Read More… from AID/APOBECs defence against SARS-CoV-2

The ESCP Goes Green #SustainableSurgery

ESCP Goes Green: Colorectal community unites to improve long-term sustainability of surgery around the globe. The European Society of Coloproctology is launching its #SustainableSurgery campaign this July. The society’s month-long focus on sustainability aims to create a movement among the colorectal community that focuses on the health of the planet, as well as of the health of […]

Read More… from The ESCP Goes Green #SustainableSurgery

The ESCP Goes Green #SustainableSurgery

ESCP Goes Green: Colorectal community unites to improve long-term sustainability of surgery around the globe. The European Society of Coloproctology is launching its #SustainableSurgery campaign this July. The society’s month-long focus on sustainability aims to create a movement among the colorectal community that focuses on the health of the planet, as well as of the health of […]

Read More… from The ESCP Goes Green #SustainableSurgery

Researchers reduce severity of sleep apnoea

New research published in The Journal of Physiology shows that researchers have successfully repurposed two existing medications to reduce the severity of sleep apnoea in people by at least 30 per cent. Affecting around 1.5 million adults in the UK, sleep apnoea is a condition where the upper airway from the back of the nose […]

Read More… from Researchers reduce severity of sleep apnoea

Researchers reduce severity of sleep apnoea

New research published in The Journal of Physiology shows that researchers have successfully repurposed two existing medications to reduce the severity of sleep apnoea in people by at least 30 per cent. Affecting around 1.5 million adults in the UK, sleep apnoea is a condition where the upper airway from the back of the nose […]

Read More… from Researchers reduce severity of sleep apnoea